In 2017, with funding from CIHR’s Partnership for Health Systems Improvement initiative, we established the Canadian Real-World Evidence for Value of Cancer Drug (CanREValue) project team. The objective for the project is to develop a framework to generate and use real-world evidence for cancer drug funding decisions. By developing a framework for the generation and use of RWE, we expect to improve system sustainability, accountability, and resource allocation that will translate into optimized drug funding and availability to patients.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.